RADHAKISHAN PHARMACEUTICALS
VELAKAST SOFOSBUVIR VELPATASVIR TABLETS

VELAKAST SOFOSBUVIR VELPATASVIR TABLETS

VELAKAST SOFOSBUVIR VELPATASVIR TABLETS Specification

  • Salt Composition
  • Sofosbuvir 400 mg + Velpatasvir 100 mg
  • Dosage Form
  • Oral tablet
  • Origin of Medicine
  • India
  • Indication
  • Treatment of adult patients with chronic hepatitis C infection of all genotypes
  • Pacakaging (Quantity Per Box)
  • 28 tablets per box
  • Drug Type
  • Allopathic
  • Ingredients
  • Sofosbuvir and Velpatasvir
  • Physical Form
  • Tablets
  • Function
  • Antiviral therapy for HCV
  • Recommended For
  • Chronic Hepatitis C Virus (HCV) Infection
  • Dosage
  • As directed by physician
  • Dosage Guidelines
  • Once daily, orally, with or without food
  • Suitable For
  • Adults
  • Quantity
  • 28 Tablets per bottle
  • Storage Instructions
  • Store below 30C, protect from moisture and light
  • Color
  • Light Pink
  • Packaging Type
  • Plastic bottle
  • Shelf Life
  • 24 months
  • Prescription Required
  • Yes
  • Warning
  • Not recommended during pregnancy or breastfeeding unless advised by a doctor
  • Shape
  • Capsule-shaped tablets
  • Brand Name
  • VELAKAST
  • Administration Route
  • Oral
  • Contraindications
  • Known hypersensitivity to Sofosbuvir, Velpatasvir, or any excipient of the formulation
  • Therapeutic Class
  • Antiviral
 

VELAKAST SOFOSBUVIR VELPATASVIR TABLETS Trade Information

  • Packaging Details
  • Pack of 28 Tablets
  • Main Domestic Market
  • All India
 

About VELAKAST SOFOSBUVIR VELPATASVIR TABLETS

Velakast Tablets 

Specifications:-

  • Brand Name : VELAKAST
  • Content: Sofosbuvir &Velpatasvir
  • Strengths: 400mg + 100mg
  • Form : Tablets 
  • Packing: Pack of 28 Tablets
  • Manufactured By: Aprazer

Note :-  VELAKAST Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............



Comprehensive Antiviral Protection

VELAKAST combines Sofosbuvir and Velpatasvir to address all genotypes of chronic hepatitis C, offering broad-spectrum efficacy. This therapy supports liver health by suppressing viral replication and curbing disease progression. As a convenient once-daily oral tablet, VELAKAST streamlines treatment protocols for adults.


Quality Assurance and Safe Packaging

Manufactured and distributed in India, VELAKAST is supplied in secure plastic bottles containing 28 tablets per box. The product ensures stability through a 24-month shelf life and rigorous protection against moisture and light. These features foster preservation of potency and facilitate safe handling by healthcare providers and patients.

FAQs of VELAKAST SOFOSBUVIR VELPATASVIR TABLETS:


Q: How should VELAKAST Sofosbuvir Velpatasvir Tablets be used for chronic hepatitis C treatment?

A: VELAKAST tablets are intended for oral administration, once daily, with or without food, as prescribed by your physician for chronic hepatitis C infection. It is important to adhere to the recommended dosage and schedule throughout the treatment period.

Q: What are the benefits of using VELAKAST for hepatitis C infection?

A: VELAKAST offers effective antiviral therapy due to its combination of Sofosbuvir and Velpatasvir, targeting all hepatitis C genotypes. This improves treatment outcomes, aids liver function, and reduces the risk of progression to severe liver diseases.

Q: When should VELAKAST not be taken?

A: VELAKAST should not be used by patients with a known hypersensitivity to Sofosbuvir, Velpatasvir, or any excipient in the formulation. It is also not recommended during pregnancy or breastfeeding unless specifically advised by a healthcare professional.

Q: Where should VELAKAST tablets be stored to maintain their effectiveness?

A: To ensure potency, VELAKAST tablets should be stored in their original plastic bottle below 30C, protected from moisture and direct light. Always keep the container tightly closed and away from children.

Q: What is the process for obtaining VELAKAST tablets?

A: VELAKAST is a prescription-only medication; you must consult a healthcare provider to receive a valid prescription. The tablets are distributed, exported, and supplied by authorized dealers in India.

Q: Can VELAKAST be taken by all adults with hepatitis C?

A: VELAKAST is suitable for adult patients diagnosed with chronic hepatitis C across all genotypes but requires medical evaluation for contraindications such as allergies to its ingredients or other health considerations.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

UNIGEF GEFITINIB TABLETS

UNIGEF GEFITINIB TABLETS

Storage Instructions : Store below 30C, protect from moisture and light

Origin of Medicine : Allopathic

Physical Form : Tablets

Drug Type : Other Types

Dosage : 250 mg

Dosage Guidelines : One tablet (250 mg) once daily or as directed by physician

RIVOFONET TENOFOVIR DISOPROXIL FUMARATE TABLETS

RIVOFONET TENOFOVIR DISOPROXIL FUMARATE TABLETS

Storage Instructions : Store below 30C in a dry place, protect from light

Origin of Medicine : Allopathic

Physical Form : Tablets

Drug Type : Other, Antiretroviral

Dosage : As directed by physician

Dosage Guidelines : Take one tablet daily or as prescribed

ENTALIV ENTECAVIR TABLETS

ENTALIV ENTECAVIR TABLETS

Storage Instructions : Store in a cool, dry place. Protect from light.

Origin of Medicine : Allopathic

Physical Form : Tablets

Drug Type : Specific Drug

Dosage : 0.5 mg / 1 mg as directed by physician

Dosage Guidelines : As prescribed by healthcare professional

PACLIWEL PACLITAXEL INJECTION

PACLIWEL PACLITAXEL INJECTION

Storage Instructions : Store below 25C, protect from light

Origin of Medicine : Allopathic

Physical Form : Other, Liquid Injection

Drug Type : Other, Prescription only, anticancer injection

Dosage : As prescribed by the physician

Dosage Guidelines : Intravenous infusion, follow physician guidance



Back to top